Literature DB >> 7931151

Adeno-associated virus type 2 interferes with early development of mouse embryos.

V Botquin1, A Cid-Arregui, J R Schlehofer.   

Abstract

The human helper-dependent adeno-associated virus type 2 (AAV-2) has been shown to induce differentiation in various cell types in culture including pluripotent embryonic cells, in the absence of helper virus. To assess whether induction of differentiation may influence developmental processes we analysed the effect of AAV-2 on developing mouse embryos. In vitro infection of fertilized eggs induced arrest of development at the two-cell stage. Moreover, micro injection of AAV-2 DNA (comprising either the complete AAV-2 genome or a fragment containing the P5 promoter region) into one-cell embryos, blocked development at the morula stage. In vivo, AAV-2 infection of pregnant mice led to fetal death and early abortion. These results demonstrate that the human adeno-associated virus, which is thought to be non-pathogenic, can perturb embryonic development in mice. This may provide a suitable animal model system to further elucidate the biological significance of the recent detection of adeno-associated virus DNA in human abortion material.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7931151     DOI: 10.1099/0022-1317-75-10-2655

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  10 in total

1.  Adeno-associated virus-2 (AAV-2) causes trophoblast dysfunction, and placental AAV-2 infection is associated with preeclampsia.

Authors:  Fabian Arechavaleta-Velasco; Yujie Ma; Jian Zhang; Cindy M McGrath; Samuel Parry
Journal:  Am J Pathol       Date:  2006-06       Impact factor: 4.307

2.  Encapsidation of adeno-associated virus type 2 Rep proteins in wild-type and recombinant progeny virions: Rep-mediated growth inhibition of primary human cells.

Authors:  D M Kube; S Ponnazhagan; A Srivastava
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

3.  Adeno-Associated Virus Vector Mobilization, Risk Versus Reality.

Authors:  Liujiang Song; R Jude Samulski; Matthew L Hirsch
Journal:  Hum Gene Ther       Date:  2020-10       Impact factor: 5.695

4.  Detection of adeno-associated virus type 2 sequences in the human genital tract.

Authors:  M Friedman-Einat; Z Grossman; F Mileguir; Z Smetana; M Ashkenazi; G Barkai; N Varsano; E Glick; E Mendelson
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

Review 5.  Adeno-Associated Virus Vectors and Stem Cells: Friends or Foes?

Authors:  Nolan Brown; Liujiang Song; Nageswara R Kollu; Matthew L Hirsch
Journal:  Hum Gene Ther       Date:  2017-06       Impact factor: 5.695

6.  Direct Injection of Recombinant AAV-Containing Solution into the Oviductal Lumen of Pregnant Mice Caused In Situ Infection of Both Preimplantation Embryos and Oviductal Epithelium.

Authors:  Masahiro Sato; Nami Sato-Yamamoto; Ai Wakita; Misako Haraguchi; Manabu Shimonishi; Hiroyuki Okuno
Journal:  Int J Mol Sci       Date:  2022-04-28       Impact factor: 6.208

7.  Ewing's Sarcoma: Development of RNA Interference-Based Therapy for Advanced Disease.

Authors:  Olivia Simmons; Phillip B Maples; Neil Senzer; John Nemunaitis
Journal:  ISRN Oncol       Date:  2012-03-11

8.  Differential suppression of the tumorigenicity of HeLa and SiHa cells by adeno-associated virus.

Authors:  P F Su; F Y Wu
Journal:  Br J Cancer       Date:  1996-06       Impact factor: 7.640

9.  Robust Long-term Transduction of Common Marmoset Neuromuscular Tissue With rAAV1 and rAAV9.

Authors:  Hironori Okada; Hidetoshi Ishibashi; Hiromi Hayashita-Kinoh; Tomoko Chiyo; Yuko Nitahara-Kasahara; Yukihiro Baba; Sumiko Watanabe; Shin'ichi Takeda; Takashi Okada
Journal:  Mol Ther Nucleic Acids       Date:  2013-05-28       Impact factor: 10.183

10.  Streamlined ex vivo and in vivo genome editing in mouse embryos using recombinant adeno-associated viruses.

Authors:  Yeonsoo Yoon; Dan Wang; Phillip W L Tai; Joy Riley; Guangping Gao; Jaime A Rivera-Pérez
Journal:  Nat Commun       Date:  2018-01-29       Impact factor: 14.919

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.